Use of a jugular vein graft in a modified Blalock-Taussig procedure in dogs

American Journal of Veterinary Research

Volumn 67, Issue 1, 2006, Pages 174-179

  Pelosi, Augusta ^a   Eyster, George E ^a   Déjardin, Loïc M ^a   Kiupel, Matti ^a   Rees, Jennifer L ^a   Richter, Marlee A ^a   Olivier, N Bari ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGRAPHY; ANIMAL EXPERIMENT; ARTICLE; AUSCULTATION; AUTOGRAFT; BLALOCK TAUSSIG ANASTOMOSIS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DOG; DOPPLER ECHOGRAPHY; EUTHANASIA; GRAFT PATENCY; HEART LEFT VENTRICLE HYPERTROPHY; HISTOLOGY; JUGULAR VEIN; LUNG ARTERY; MALE; NONHUMAN; OXIMETRY; SUBCLAVIAN ARTERY; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VASCULAR ACCESS; VEIN GRAFT; VETERINARY MEDICINE;

ANALYSIS OF VARIANCE; ANGIOGRAPHY; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; DOGS; JUGULAR VEINS; TRANSPLANTS; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

ANIMALIA; CANIS FAMILIARIS;

EID: 33645228932     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.67.1.174     Document Type: Article

References (33)

1. Webb GD, Smallhorn JF, Therrien J. Congenital heart disease in infancy and childhood. In: Zipes DP, Libby P, Bonow RO, eds. Braunswald's heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders, 2005;1489-1552.
2. Kittleson MD. Tetralogy of Fallot. In: Kittleson MD, Kienle RD, eds. Small animal cardiovascular medicine. St Louis: Mosby Year Book Inc, 1998;240-247.
3. Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of Fallot in the neonate. Ann Surg 2000;232:508-514.
4. Kirklin JW, Blackstone EH, Kirklin JK, et al. Surgical repair and protocol in the spectrum of Tetralogy of Fallot. Ann Thorac Surg 1983;198:251-265.
5. Cooley DA. Palliative surgery for cyanotic congenital heart disease. Surg Clin North Am 1988;68:477-496.
6. Bove EL, Sondheimer HM, Kavey RE, et al. Subclavian-pulmonary artery shunts with polytetrafluorethylene interposition grafts. Ann Thorac Surg 1984;37:88-91.
7. Tamisier D, Vouhe PR, Vernant F, et al. Modified Blalock-Taussig shunts: results in infants less than 3 months of age. Ann Thorac Surg 1990;49:797-801.
8. Ilbawi MN, Grieco J, DeLeon SY, et al. Modified Blalock-Taussig shunt in newborn infants. J Thorac Cardiovasc Surg 1984;88:770-775.
9. Gladman G, McCrindle BW, Williams WG, et al. The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. J Thorac Cardiovasc Surg 1997; 114:25-30.
10. Blalock A, Taussig HB. The surgical treatment of the heart in which there is pulmonary stenosis and pulmonary atresia. JAMA 1945;128:189-202.
11. Lawless CE, Smith EE, Hallidie-Smith K, et al. The modified Blalock-Taussig shunt using microporous expanded polytetrafluoroethylene (PTFE). J Cardiovasc Surg (Torino) 1982;23:287-292.
12. Donahoo JS, Gardner TJ, Zahka K, et al. Systemic-pulmonary shunts in neonates and infants using microporous expanded polytetrafluoroethylene: immediate and late results. Ann Thorac Surg 1980;30:146-150.
13. Nanton MA, Roy DL, Murphy DM, et al. Polytetrafluoroethylene shunts in congenital heart disease. Can J Surg 1982;25:134-138.
14. Opie JC, Traverse L, Hayden RI, et al. Experience with polytetrafluoroethylene grafts in children with cyanotic congenital heart disease. Ann Thorac Surg 1986;41:164-168.
15. Herrtage ME, Hall LW, English TA. Surgical correction of the tetralogy of Fallot in a dog. J Small Anim Pract 1983;24:51-62.
16. Lew LJ, Fowler JD, McKay R, et al. Open-heart correction of tetralogy of Fallot in an acyanotic dog. J Am Vet Med Assoc 1998;213:652-657.
17. Orton EC, Mama K, Hellyer P, et al. Open surgical repair of tetralogy of Fallot in dogs. J Am Vet Med Assoc 2001;219:1089-1093.
18. Eyster GE, Braden TD, Appleford M, et al. Surgical management of tetralogy of Fallot. J Small Anim Pract 1977;18:387-394.
19. Ringwald RJ, Bonagura JD. Tetralogy of Fallot in the dog: clinical findings in 13 cases. J Am Anim Hosp Assoc 1988;24:33-43.
20. Danilowicz D, Ishmael RG, Doyle EF, et al. Use of saphenous vein allografts for aortopulmonary artery anastomoses in neonates with complex cyanotic congenital heart disease. Pediatr Cardiol 1984;5:13-17.
21. Senno A, Slovis AJ, Kahn RE, et al. Interposition of the azygous vein in the Blalock-Taussig procedure. Surg Gynecol Obstet 1975;141:929-930.
22. Bogats G, Kertesz E, Katona M, et al. Modified Blalock-Taussig shunt using allograft saphenous vein: six years' experience. Ann Thorac Surg 1996;61:58-62.
23. Tam VK, Murphy K, Parks WJ, et al. Saphenous vein homograft: a superior conduit for the systemic arterial shunt in the Norwoodoperation. Ann Thorac Surg 2001;71:1537-1540.
24. Kalangos A, Beghetti M, Pache JC, et al. Systemic pulmonary artery shunt using a bovine mesenteric venous graft in newborns. J Card Surg 2000;15:239-243.
25. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
26. Boon JA. Evaluation of size, function, and hemodynamics. In: Boon JA, ed. Manual of veterinary echocardiography. Baltimore: The Williams & Wilkins Co, 1998;151-236.
27. Patrick DJ, Kiupel M, Gerber V, et al, Malignant granulosatheca cell tumor in a 2-year-old Miniature Horse. J Vet Diagn Invest 2003;15:60-63.
28. De Leval MR, McKay R, Jones M, et al. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts. J Thorac Cardiovasc Surg 1981;81:112-119.
29. Kusuhara K, Miki S, Ueda Y. Optimal flow of aorta-pulmonary artery shunt in patients with cyanotic heart disease. Ann Thorac Surg 1987;44:128-134.
30. Sreeram N, Walsh K, Peart I. Recanalization of an occluded modified Blalock-Taussig shunt by balloon dilation. Br Heart J 1993;70:474-475.
31. Ariyoshi H, Okuyama M, Okahara K, et al. Expanded polytetrafluoroethylene vascular graft loses its thrombogenicity six months after implantation. Thromb Res 1997;88:427-433.
32. Anderson JE, Chang AS, Anstadt MP, et al. Polytetrafluoroethylene hemoaccess site infections. ASAIO J 2000; 46:18-21.
33. Bosman PJ, Blankestijin PJ, Van der Graaf Y, et al. A comparison between randomized PTFE and denaturated homologous vein graft for haemodialysis access: a prospective randomised multicentre trial. The SMASH Study Group. Study of Graft Materials in Access for Haemodialysis. Eur J Vasc Endovasc Surg 1998;16:126-132.